Jiangsu Hengrui Medicine Co., Ltd.
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
1/10
|
65.24 | 41.44 | 57.44% | 73 | -10.64% |
| P/S |
|
12.3 | 20 | -38.5% |
|
|
| P/BV |
|
6.84 | 3.7 | 85% |
|
|
| P/FCF |
|
41.37 | 80.43 | -48.56% |
|
|
| Ev/Ebitda |
|
60.74 | 16.62 | 265.38% |
|
|
| Ev/S |
|
10.47 | 23.5 | -55.44% |
|
|
| Ev/FCF |
|
38.79 | 83.06 | -53.29% |
|
|
| E/P |
|
0.0169 | 0.0217 | -22.05% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
6/10
|
19.94 | -84.6 | -123.57% | 21.12 | -5.58% |
| ROE |
|
10.99 | 6.66 | 65.06% |
|
|
| ROA |
|
9.99 | 3.59 | 178.02% |
|
|
| ROIC |
|
0 | 0 | 0% |
|
|
| ROS |
|
18.85 | -76.53 | -124.63% |
|
|
| ROCE |
|
0 | 1.78 | -100% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
0.0206 | 0.7401 | -97.21% | 0.0206 | 0% |
| Nеt Debt/Ebitda |
|
0 | -0.1073 | -100% |
|
|
| Debt/Ratio |
|
0.0021 | 0.1017 | -97.89% |
|
|
| Debt/Equity |
|
0.003 | 0.2121 | -98.57% |
|
|
| Debt/Net Income |
|
0.0218 | 1.29 | -98.31% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 0.3991 | -100% | 0.3119 | -100% |
| Number of years of dividend growth |
|
0 | 1 | -100% | ||
| DSI |
|
0.7857 | 0.6935 | 13.3% |
|
|
| Average dividend growth |
|
13.8 | 3.04 | 353.87% |
|
|
| Average percentage for 5 years |
|
0.3119 | 1.4 | -77.68% |
|
|
| Average percentage for payments |
|
19.32 | 45.07 | -57.13% |
|
|
| Difference from average difference in sector |
|
-0.3991 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
0/10
|
-2.01 | -94.63 | -97.88% | ||
| Growth impulse Ebitda in 5 years |
|
-41.18 | 12.85 | -420.47% | ||
| Growth impulse Net Income in 5 years |
|
-19.25 | -157.35 | -87.77% | ||
| Growth impulse FCF in 5 years |
|
89.22 | -361.32 | -124.69% | ||
| Growth impulse EPS in 5 years |
|
-23.36 | -109.66 | -78.7% |
IP Score
4.37/10
